Table 3.

Reporting Odds Ratios of adverse events of special interest as measured by comparing BNT162b2 with mRNA-1273 (ROR₁) and vice-versa (ROR₂).

Events	N BNT162b2	N mRNA-1273	ROR1	ROR2	CI_low1	CI_up1	CI_low2	CI_up2
Myocarditis	3989	1310	2.00	0.50	1.93	2.06	0.47	0.53
Pericarditis	2785	743	2.46	0.41	2.36	2.56	0.38	0.44
Bell's palsy	2891	1417	1.34	0.75	1.29	1.39	0.71	0.79
Guillain-Barré syndrome	843	295	1.87	0.53	1.74	2.02	0.48	0.60
Anaphylactic reaction	5004	1233	2.66	0.38	2.59	2.74	0.35	0.40
Anaphylactic shock	700	142	3.23	0.31	2.96	3.53	0.26	0.37
Thrombosis	3291	1291	1.67	0.60	1.61	1.73	0.57	0.63
Deep vein thrombosis	3156	1086	1.91	0.52	1.84	1.98	0.49	0.56
Thrombocytopenia	1424	403	2.31	0.43	2.19	2.45	0.39	0.48